Evidence map›Paper›PMID 23878193›Full record

ReviewThe Journal of biological chemistry2013

The concept of allosteric interaction and its consequences for the chemistry of the brain.

Jean-Pierre Changeux

Open access · hybridAbstract readHistorical ArticleReview
In one paragraph

Review in The Journal of biological chemistry, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Acta pharmaceutica Sinica. B · 2024
    Review
  3. RNA aptamers for AMPA receptors.Neuropharmacology · 2021
    Review
  4. Binding site location on GABABritish journal of pharmacology · 2019
    Article
  5. The nicotinic acetylcholine receptor: a typical 'allosteric machine'.Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2018
    Review
  6. Review
  7. Article
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Jean-Pierre ChangeuxCollège de France, 75005 Paris and the Institut Pasteur, 75724 Paris Cedex 15, France. Electronic address: changeux@noos.fr.
Collège de France · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Throughout this Reflections article, I have tried to follow up on the genesis in the 1960s and subsequent evolution of the concept of allosteric interaction and to examine its consequences within the past decades, essentially in the field of the neuroscience. The main conclusion is that allosteric mechanisms built on similar structural principles operate in bacterial regulatory enzymes, gene repressors (and the related nuclear receptors), rhodopsin, G-protein-coupled receptors, neurotransmitter receptors, ion channels, and so on from prokaryotes up to the human brain yet with important features of their own. Thus, future research on these basic cybernetic sensors is expected to develop in two major directions: at the elementary level, toward the atomic structure and molecular dynamics of the conformational changes involved in signal recognition and transduction, but also at a higher level of organization, the contribution of allosteric mechanisms to the modulation of brain functions.

Indexed as

Models, BiologicalMolecular Dynamics SimulationAllosteric RegulationBrain ChemistryHistory, 20th CenturyHistory, 21st CenturyHumansNerve Tissue ProteinsPortraits as TopicProkaryotic CellsNerve Tissue ProteinsAllosteric RegulationMembrane ProteinsNeuronsNicotinic Acetylcholine ReceptorsSynaptic Plasticity

Identifiers

PMID23878193
PMCPMC3779700
OpenAlexW2018235516

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.